Fengfeng Xu

941 total citations
22 papers, 638 citations indexed

About

Fengfeng Xu is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Fengfeng Xu has authored 22 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Genetics. Recurrent topics in Fengfeng Xu's work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Bacterial Genetics and Biotechnology (4 papers). Fengfeng Xu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Bacterial Genetics and Biotechnology (4 papers). Fengfeng Xu collaborates with scholars based in United States, China and New Zealand. Fengfeng Xu's co-authors include Robert C. Bast, C. Boyer, Pak‐Lam Yu, Gordon B. Mills, L. E. Pearce, Yinhua Yu, Kathy O'Briant, Jeffrey B. Ulmer, Hong Liu and Jing Zhao and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Microbiology.

In The Last Decade

Fengfeng Xu

21 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengfeng Xu United States 13 272 183 168 152 121 22 638
David Ruano‐Gallego Spain 17 487 1.8× 32 0.2× 140 0.8× 240 1.6× 131 1.1× 30 946
Cyril J. Cohen Israel 14 347 1.3× 88 0.5× 320 1.9× 90 0.6× 263 2.2× 17 988
Claude V. Déry Canada 13 293 1.1× 148 0.8× 70 0.4× 179 1.2× 32 0.3× 22 505
Christopher G. Ullman United Kingdom 17 541 2.0× 57 0.3× 82 0.5× 70 0.5× 217 1.8× 29 803
Philippe Mondon France 19 338 1.2× 136 0.7× 130 0.8× 26 0.2× 243 2.0× 38 836
Lorraine Johnsrud United States 8 615 2.3× 118 0.6× 121 0.7× 301 2.0× 113 0.9× 10 916
Maria Elena Villani Italy 15 445 1.6× 241 1.3× 110 0.7× 38 0.3× 266 2.2× 25 747
Annie Findeli France 11 478 1.8× 39 0.2× 148 0.9× 406 2.7× 29 0.2× 15 803
Gregory N. Weddell United States 8 455 1.7× 48 0.3× 89 0.5× 106 0.7× 106 0.9× 8 874
Rosana Sánchez‐López Mexico 19 476 1.8× 390 2.1× 137 0.8× 58 0.4× 34 0.3× 42 1.1k

Countries citing papers authored by Fengfeng Xu

Since Specialization
Citations

This map shows the geographic impact of Fengfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfeng Xu more than expected).

Fields of papers citing papers by Fengfeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfeng Xu. The network helps show where Fengfeng Xu may publish in the future.

Co-authorship network of co-authors of Fengfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengfeng Xu. A scholar is included among the top collaborators of Fengfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengfeng Xu. Fengfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mukhopadhyay, Rituparna, et al.. (2022). Salmonella Subpopulations Identified from Human Specimens Express Heterogenous Phenotypes That Are Relevant to Clinical Diagnosis. Microbiology Spectrum. 11(1). e0167922–e0167922. 1 indexed citations
3.
Hao, Chenyang, Chengzhi Jiao, Jian Hou, et al.. (2020). Resequencing of 145 Landmark Cultivars Reveals Asymmetric Sub-genome Selection and Strong Founder Genotype Effects on Wheat Breeding in China. Molecular Plant. 13(12). 1733–1751. 153 indexed citations
4.
Zhu, Liancheng, et al.. (2019). [Clinicopathological features of ovarian Brenner tumors].. PubMed. 48(8). 615–619. 3 indexed citations
5.
Xu, Fengfeng & Jeffrey B. Ulmer. (2003). AttenuatedSalmonellaandShigellaas Carriers for DNA Vaccines. Journal of drug targeting. 11(8-10). 481–488. 16 indexed citations
6.
Xu, Fengfeng. (2003). Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella. Vaccine. 21(7-8). 644–648. 30 indexed citations
7.
Xu, Fengfeng, Steven A. Leadon, Yinhua Yu, et al.. (2000). Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.. PubMed. 6(8). 3334–41. 11 indexed citations
8.
Xu, Fengfeng, Wei Xia, Sihai Zhao, et al.. (2000). The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice.. PubMed. 60(17). 4913–20. 29 indexed citations
9.
Otten, Gillis R., Barbara Doe, Mary Schaefer, et al.. (2000). Relative Potency of Cellular and Humoral Immune Responses Induced by DNA Vaccination. Intervirology. 43(4-6). 227–232. 22 indexed citations
10.
Bast, Robert C., Yan Yu, Fengfeng Xu, Le Xiao, & Gordon B. Mills. (2000). Molecular approaches to management of epithelial ovarian cancer. International Journal of Gynecological Cancer. 10(s1). 2–7. 12 indexed citations
11.
Xu, Fengfeng, et al.. (1999). The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression.. PubMed. 5(11). 3653–60. 58 indexed citations
12.
Dean, Gillian S., Lajos Pusztai, Fengfeng Xu, et al.. (1998). Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells.. PubMed. 4(10). 2545–50. 24 indexed citations
13.
Martell, Robert E., et al.. (1998). OVX1 and CEA in Patients with Colon Carcinoma, Colon Polyps and Benign Colon Disorders. The International Journal of Biological Markers. 13(3). 145–149. 3 indexed citations
14.
Xu, Fengfeng, C. Boyer, Kathy O'Briant, et al.. (1997). Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.. PubMed. 3(9). 1629–34. 61 indexed citations
15.
Xu, Fengfeng. (1997). Radioiodinated Antibody Targeting of the HER-2/neu Oncoprotein. Nuclear Medicine and Biology. 24(5). 451–459. 3 indexed citations
16.
Yu, Yanke, Stanley C. Henry, Fengfeng Xu, & John D. Hamilton. (1995). Expression of a Murine Cytomegalovirus Early-Late Protein in "Latently" Infected Mice. The Journal of Infectious Diseases. 172(2). 371–379. 15 indexed citations
17.
Xu, Fengfeng, L. E. Pearce, & Pak‐Lam Yu. (1991). Genetic analysis of a lactococcal plasmid replicon. Molecular and General Genetics MGG. 227(1). 33–39. 35 indexed citations
18.
Xu, Fengfeng, L. E. Pearce, & Pak‐Lam Yu. (1991). Construction of a family of lactococcal vectors for gene cloning and translational fusion. FEMS Microbiology Letters. 77(1). 55–60. 21 indexed citations
19.
Maier, Lisa A., Fengfeng Xu, Svenja Hester, et al.. (1991). Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2.. PubMed. 51(19). 5361–9. 65 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Ruano‐Gallego Breakdown of academic impact, for papers by Cyril J. Cohen Breakdown of academic impact, for papers by Claude V. Déry Breakdown of academic impact, for papers by Christopher G. Ullman Breakdown of academic impact, for papers by Philippe Mondon Breakdown of academic impact, for papers by Lorraine Johnsrud Breakdown of academic impact, for papers by Maria Elena Villani Breakdown of academic impact, for papers by Annie Findeli Breakdown of academic impact, for papers by Gregory N. Weddell Breakdown of academic impact, for papers by Rosana Sánchez‐López
Rankless by CCL
2026